Compounds > capecitabine
Page last updated: 2024-08-24

capecitabine and Carcinoma, Medullary

capecitabine has been researched along with Carcinoma, Medullary in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brun, V; Gravis, G; Labidi, SI; Tarpin, C; Viens, P1
Michelin, OC; Paiva, CE1

Other Studies

2 other study(ies) available for capecitabine and Carcinoma, Medullary

ArticleYear
Medullary thyroid cancer treated by capecitabine.
    Anti-cancer drugs, 2007, Volume: 18, Issue:7

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Capecitabine; Carcinoma, Medullary; Cisplatin; Deoxycytidine; Doxorubicin; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Metastasis; Palliative Care; Thyroid Neoplasms; Treatment Outcome

2007
Use of capecitabine in refractory metastatic medullary thyroid carcinoma.
    Thyroid : official journal of the American Thyroid Association, 2008, Volume: 18, Issue:5

    Topics: Adult; Antimetabolites, Antineoplastic; Capecitabine; Carcinoma, Medullary; Deoxycytidine; Fluorouracil; Humans; Male; Neoplasm Metastasis; Thyroid Neoplasms

2008